Shareholders to Vote on 64% Potential Dilution and Board Changes; Compliance Lapses Noted

summarizeSummary

Landmark Bancorp's definitive proxy details a shareholder vote on a proposal to increase authorized shares, enabling potential 64% dilution, and discloses multiple late insider trading reports.

check_boxKey Events

• Authorized Stock Increase Proposal

  Shareholders will vote on increasing authorized common stock from 7.5 million to 10 million shares. If all newly authorized shares were issued, it would represent a potential dilution of 64% to existing shareholders. The company seeks this flexibility for future capital raises, stock dividends, or acquisitions, though no immediate plans are disclosed. This proposal was previously outlined in a PRE 14A filing on April 10, 2026.

• Delinquent Insider Trading Reports

  The filing reveals several late Section 16(a) reports, including six transactions from the former Principal Executive Officer, Michael E. Scheopner, three from Chairman Patrick L. Alexander, and one Form 3 from director Thomas A. Page. This indicates a lapse in timely compliance reporting by key insiders.

• Director Re-election and Departure

  Three Class I directors are up for re-election. Sarah Hill-Nelson, a Class I director for 15 years, is not standing for re-election, which will reduce the board size from eleven to ten directors.

• Auditor Ratification

  Stockholders are asked to ratify the appointment of Forvis Mazars, LLP as the independent registered public accounting firm for 2026, following the dismissal of Crowe LLP on February 23, 2026. No disagreements or reportable events were reported in connection with the auditor change, which was previously disclosed in an 8-K filing on February 27, 2026.

auto_awesomeAnalysis

The definitive proxy statement outlines key proposals for the upcoming annual meeting, including a significant increase in authorized common stock that could lead to 64% dilution if all shares were issued. While the company states no immediate plans for issuance, this authorization provides substantial flexibility for future capital raises or acquisitions. The filing also reveals multiple delinquent Section 16(a) reports from the Chairman, former CEO, and a director, indicating compliance oversight issues.